.

Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Fish and Richardson
US Department of Justice
Argus Health
Cipla
Covington
Medtronic
AstraZeneca
UBS
Dow

Generated: December 13, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021090

« Back to Dashboard

NDA 021090 describes CYCLESSA, which is a drug marketed by Aspen Global Inc and is included in one NDA. It is available from one supplier. Additional details are available on the CYCLESSA profile page.

The generic ingredient in CYCLESSA is desogestrel; ethinyl estradiol. There are eight drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the desogestrel; ethinyl estradiol profile page.

Summary for 021090

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 021090

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CYCLESSA desogestrel; ethinyl estradiol TABLET;ORAL-28 021090 NDA Aspen Global Inc. 76388-283 76388-283-01 1 BLISTER PACK in 1 BOX (76388-283-01) > 1 KIT in 1 BLISTER PACK

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORAL-28Strength0.1MG,0.125MG,0.15MG;0.025MG,0.025MG,0.025MG
Approval Date:Dec 20, 2000TE:ABRLD:Yes

Expired Orange Book Patents for NDA: 021090

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Aspen Global IncCYCLESSAdesogestrel; ethinyl estradiolTABLET;ORAL-28021090-001Dec 20, 2000► Subscribe► Subscribe
Aspen Global IncCYCLESSAdesogestrel; ethinyl estradiolTABLET;ORAL-28021090-001Dec 20, 2000► Subscribe► Subscribe
Aspen Global IncCYCLESSAdesogestrel; ethinyl estradiolTABLET;ORAL-28021090-001Dec 20, 2000► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Fuji
UBS
McKesson
Teva
McKinsey
Mallinckrodt
Cipla
Federal Trade Commission
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot